Follow
Phaedra Eleftheriou
Phaedra Eleftheriou
International Hellenic University
Verified email at ihu.gr
Title
Cited by
Cited by
Year
Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition
AA Geronikaki, AA Lagunin, DI Hadjipavlou-Litina, PT Eleftheriou, ...
Journal of medicinal chemistry 51 (6), 1601-1609, 2008
2072008
Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents
O Kouatly, A Geronikaki, C Kamoutsis, D Hadjipavlou-Litina, P Eleftheriou
European journal of medicinal chemistry 44 (3), 1198-1204, 2009
1222009
2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action
A Geronikaki, P Eleftheriou, P Vicini, I Alam, A Dixit, AK Saxena
Journal of medicinal chemistry 51 (17), 5221-5228, 2008
1182008
Fragment-based design, docking, synthesis, biological evaluation and structure–activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as …
P Eleftheriou, A Geronikaki, D Hadjipavlou-Litina, P Vicini, O Filz, ...
European journal of medicinal chemistry 47, 111-124, 2012
852012
Synthesis and in silico biological activity evaluation of new N-substituted pyrazolo-oxazin-2-one systems
N Benaamane, B Nedjar-Kolli, Y Bentarzi, L Hammal, A Geronikaki, ...
Bioorganic & medicinal chemistry 16 (6), 3059-3066, 2008
772008
New analogues of butylated hydroxytoluene as anti-inflammatory and antioxidant agents
GN Ziakas, EA Rekka, AM Gavalas, PT Eleftheriou, PN Kourounakis
Bioorganic & medicinal chemistry 14 (16), 5616-5624, 2006
722006
In silico evaluation of the effectivity of approved protease inhibitors against the main protease of the novel SARS-CoV-2 virus
P Eleftheriou, D Amanatidou, A Petrou, A Geronikaki
Molecules 25 (11), 2529, 2020
532020
5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation
M Fesatidou, P Zagaliotis, C Camoutsis, A Petrou, P Eleftheriou, C Tratrat, ...
Bioorganic & Medicinal Chemistry 26 (16), 4664-4676, 2018
432018
Synthesis and pharmacochemical study of novel polyfunctional molecules combining anti-inflammatory, antioxidant, and hypocholesterolemic properties
CM Doulgkeris, D Galanakis, AP Kourounakis, KC Tsiakitzis, AM Gavalas, ...
Bioorganic & medicinal chemistry letters 16 (4), 825-829, 2006
332006
PTP1b inhibition, a promising approach for the treatment of diabetes type II
P Eleftheriou, A Geronikaki, A Petrou
Current Topics in Medicinal Chemistry 19 (4), 246-263, 2019
322019
Serum antioxidant status among young, middle-aged and elderly people before and after antioxidant rich diet
E Limberaki, P Eleftheriou, E Vagdatli, V Kostoglou, C Petrou
Hippokratia 16 (2), 118, 2012
322012
Application of docking analysis in the prediction and biological evaluation of the lipoxygenase inhibitory action of thiazolyl derivatives of mycophenolic acid
E Tsolaki, P Eleftheriou, V Kartsev, A Geronikaki, AK Saxena
Molecules 23 (7), 1621, 2018
282018
Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile
GN Ziakas, EA Rekka, AM Gavalas, PT Eleftheriou, KC Tsiakitzis, ...
Bioorganic & medicinal chemistry 13 (23), 6485-6492, 2005
242005
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity
F Esposito, FA Ambrosio, R Maleddu, G Costa, R Rocca, E Maccioni, ...
European Journal of Medicinal Chemistry 182, 111617, 2019
232019
Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo [d] thiazol-2-yl) thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism
E Pitta, A Geronikaki, S Surmava, P Eleftheriou, VP Mehta, ...
Journal of enzyme inhibition and medicinal chemistry 28 (1), 113-122, 2013
222013
Design, synthesis, evaluation of antimicrobial activity and docking studies of new thiazole-based chalcones
C Tratrat, M Haroun, I Xenikakis, K Liaras, E Tsolaki, P Eleftheriou, ...
Current Topics in Medicinal Chemistry 19 (5), 356-375, 2019
202019
Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis …
P Eleftheriou, A Petrou, A Geronikaki, K Liaras, S Dirnali, M Anna
SAR and QSAR in Environmental Research 26 (7-9), 557-576, 2015
202015
Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives
CA Ganou, PT Eleftheriou, P Theodosis-Nobelos, M Fesatidou, ...
SAR and QSAR in Environmental Research 29 (2), 133-149, 2018
182018
Rational use of heterogeneous data in quantitative structure–activity relationship (QSAR) modeling of cyclooxygenase/lipoxygenase inhibitors
AA Lagunin, A Geronikaki, P Eleftheriou, PV Pogodin, AV Zakharov
Journal of chemical information and modeling 59 (2), 713-730, 2019
172019
Anti-HIV agents: current status and recent trends
A Geronikaki, P Eleftheriou, V Poroikov
Communicable Diseases of the Developing World, 37-95, 2016
172016
The system can't perform the operation now. Try again later.
Articles 1–20